Skip to main content

Seminars in Arthritis and Rheumatism

  • ISSN: 0049-0172

Editor-In-Chief: Hochberg

Next planned ship date: June 4, 2024

  • 5 Year impact factor: 5.4
  • Impact factor: 5

With a CiteScore of 9.1 and an Impact Factor of 5.431, Seminars in Arthritis and Rheumatism provides access to the highest-quality clinical, therapeutic and translational research… Read more

Subscription options

Next planned ship date:
June 4, 2024

Institutional subscription on ScienceDirect

Request a sales quote
With a CiteScore of 9.1 and an Impact Factor of 5.431, Seminars in Arthritis and Rheumatism provides access to the highest-quality clinical, therapeutic and translational research about arthritis, rheumatology and musculoskeletal disorders. Each bimonthly issue includes articles giving you the latest diagnostic criteria, consensus statements, systematic reviews and meta-analyses as well as clinical and translational research studies. Read this journal for the latest groundbreaking research and to gain insights from scientists and clinicians on the management and treatment of musculoskeletal and autoimmune rheumatologic diseases. The journal is of interest to rheumatologists, internal medicine physicians, immunologists and specialists in bone and mineral metabolism. Seminars in Arthritis and Rheumatism no longer publishes single case reports, even when accompanied by a systematic literature review, unsolicited narrative reviews or results of analyses using either uni- or bi-directional Mendelian randomization for analysis of genetic associations of risk factors with disease.